Below are the most recent publications written about "Malaria, Falciparum" by people in Profiles.
-
Leuba SI, Westreich D, Bose CL, Olshan AF, Taylor SM, Tshefu A, Lokangaka A, Carlo WA, Chomba E, Mwenechanya M, Liechty EA, Bucher SL, Ekhaguere OA, Esamai F, Nyongesa P, Jessani S, Saleem S, Goldenberg RL, Moore JL, Nolen TL, Hemingway-Foday J, McClure EM, Koso-Thomas M, Derman RJ, Hoffman M, Meshnick SR, Bauserman M. Effects on maternal and pregnancy outcomes of first-trimester malaria infection among nulliparous women from Kenya, Zambia, and the Democratic Republic of the Congo. PLoS One. 2024; 19(12):e0310339.
-
Mangou K, Moore AJ, Thiam LG, Ba A, Orfan? A, Desamours I, Ndegwa DN, Goodwin J, Guo Y, Sheng Z, Patel SD, Diallo F, Sene SD, Pouye MN, Faye AT, Thiam A, Nunez V, Diagne CT, Sadio BD, Shapiro L, Faye O, Mbengue A, Bei AK. Structure-guided insights into potential function of novel genetic variants in the malaria vaccine candidate PfRh5. Sci Rep. 2022 11 12; 12(1):19403.
-
Leuba SI, Westreich D, Bose CL, Powers KA, Olshan A, Taylor SM, Tshefu A, Lokangaka A, Carlo WA, Chomba E, Liechty EA, Bucher SL, Esamai F, Jessani S, Saleem S, Goldenberg RL, Moore J, Nolen T, Hemingway-Foday J, McClure EM, Koso-Thomas M, Derman RJ, Hoffman M, Bauserman M. Predictors of Plasmodium falciparum Infection in the First Trimester Among Nulliparous Women From Kenya, Zambia, and the Democratic Republic of the Congo. J Infect Dis. 2022 06 01; 225(11):2002-2010.
-
Gaur AH, Panetta JC, Smith AM, Dallas RH, Freeman BB, Stewart TB, Tang L, John E, Branum KC, Patel ND, Ost S, Heine RN, Richardson JL, Hammill JT, Bebrevska L, Gusovsky F, Maki N, Yanagi T, Flynn PM, McCarthy JS, Chalon S, Guy RK. Combining SJ733, an oral ATP4 inhibitor of Plasmodium falciparum, with the pharmacokinetic enhancer cobicistat: An innovative approach in antimalarial drug development. EBioMedicine. 2022 Jun; 80:104065.
-
Lang SS, Paden W, Steenhoff AP, Hines K, Storm PB, Huh J. Intracranial Pressure and Brain Tissue Oxygen Neuromonitoring in Pediatric Cerebral Malaria. World Neurosurg. 2020 09; 141:115-118.
-
Gaur AH, McCarthy JS, Panetta JC, Dallas RH, Woodford J, Tang L, Smith AM, Stewart TB, Branum KC, Freeman BB, Patel ND, John E, Chalon S, Ost S, Heine RN, Richardson JL, Christensen R, Flynn PM, Van Gessel Y, Mitasev B, M?hrle JJ, Gusovsky F, Bebrevska L, Guy RK. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial. Lancet Infect Dis. 2020 08; 20(8):964-975.
-
de Lima Corvino DF, Chandorkar AA, Mora Carpio AL, Climaco A. When Epidemiology Is the Clue to a Positive Outcome: A Case of Malaria During Pregnancy. Am J Case Rep. 2018 Feb 05; 19:128-132.
-
Elphinstone RE, Riley F, Lin T, Higgins S, Dhabangi A, Musoke C, Cserti-Gazdewich C, Regan RF, Warren HS, Kain KC. Dysregulation of the haem-haemopexin axis is associated with severe malaria in a case-control study of Ugandan children. Malar J. 2015 Dec 21; 14:511.
-
Milani KJ, Schneider TG, Taraschi TF. Defining the morphology and mechanism of the hemoglobin transport pathway in Plasmodium falciparum-infected erythrocytes. Eukaryot Cell. 2015 Apr; 14(4):415-26.
-
Gaieski DF, Goldman JD, Holtzman DL, Shoff WH, Shepherd SM, Mehta N, Goyal M. Algid malaria treated with early goal-directed therapy. Am J Emerg Med. 2013 Jan; 31(1):263.e5-10.